FdaApplication

ANDA 214310

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeANDA
approval_date2025-06-09

Products (1)

ProductActive ingredientStrengthDosage form
ERIBULIN MESYLATEERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION;INTRAVENOUS

1 product